ITGB1 and neoplasm: Several tumor initiating and/or promoting pathways including epidermal growth factor (EGF) and vascular endothelial growth factor-mediated signaling pathways activate the RAS-MAP kinase cascade for ITGB1 transcription through downstream AP-1 family transcription factors.